<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>094</observationCode>
<observationTitle>Severe allergic reaction after previous dose of Pneumococcal</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of Pneumococcal vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
<vaccine>
<contraindication>
<observationCode>117</observationCode>
<observationTitle>Severe allergic reaction to diphtheria toxoid</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to diphtheria toxoid.</contraindicationText>
<contraindicationGuidance/>
<contraindicatedVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge/>
<endAge/>
</contraindicatedVaccine>
</contraindication>
</vaccine>
</contraindications>
<series>
<seriesName>Pneumococcal 4-dose series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>12 months - 4 days</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>6 weeks - 4 days</absMinAge>
<minAge>6 weeks</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>10 weeks - 4 days</absMinAge>
<minAge>10 weeks</minAge>
<earliestRecAge>4 months</earliestRecAge>
<latestRecAge>5 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>13 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Evaluation</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Target Dose not required if current dose was administered on or after 24 months - 4 days of age.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>24 months - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<conditionalSkip>
<context>Forecast</context>
<setLogic>n/a</setLogic>
<set>
<setID>2</setID>
<setDescription>Target Dose not required for those who are 24 months of age or older.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>24 months</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge>14 weeks - 4 days</absMinAge>
<minAge>14 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>7 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>13 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Evaluation</context>
<setLogic>OR</setLogic>
<set>
<setID>1</setID>
<setDescription>Target Dose is not required if the current dose was administered on or after 12 months of age</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>12 months</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
<set>
<setID>2</setID>
<setDescription>Target Dose is not required if the current dose was administered on or after 12 months - 4 days of age AND at least 8 weeks - 4 days from the previous dose</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic>AND</conditionLogic>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
<condition>
<conditionID>2</conditionID>
<conditionType>Interval</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval>8 weeks - 4 days</interval>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<conditionalSkip>
<context>Forecast</context>
<setLogic>n/a</setLogic>
<set>
<setID>3</setID>
<setDescription>Dose is not required for those 12 months or older</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>12 months</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge>12 months - 4 days</absMinAge>
<minAge>12 months</minAge>
<earliestRecAge>12 months</earliestRecAge>
<latestRecAge>16 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 5</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more doses of PCV13</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal dose 2 at 7 months series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>12 months - 4 days</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>6 weeks - 4 days</absMinAge>
<minAge>6 weeks</minAge>
<earliestRecAge>2 months</earliestRecAge>
<latestRecAge>3 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>10 weeks - 4 days</absMinAge>
<minAge>10 weeks</minAge>
<earliestRecAge>4 months</earliestRecAge>
<latestRecAge>5 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>13 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required for those 7 months or older</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Age</conditionType>
<startDate/>
<endDate/>
<beginAge>7 months - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge>14 weeks - 4 days</absMinAge>
<minAge>14 weeks</minAge>
<earliestRecAge>6 months</earliestRecAge>
<latestRecAge>7 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>4 weeks - 4 days</absMinInt>
<minInt>4 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>13 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 4</doseNumber>
<age>
<absMinAge>12 months - 4 days</absMinAge>
<minAge>12 months</minAge>
<earliestRecAge>12 months</earliestRecAge>
<latestRecAge>16 months + 4 weeks</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>6 months</earliestRecInt>
<latestRecInt>7 months + 4 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 5</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more doses of PCV13</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal start at 12 months series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart/>
<maxAgeToStart>24 months - 4 days</maxAgeToStart>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>12 months - 4 days</absMinAge>
<minAge>12 months</minAge>
<earliestRecAge>12 months</earliestRecAge>
<latestRecAge>12 months</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more doses of PCV13</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>12 months - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal start at 24 months series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups>2</equivalentSeriesGroups>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>4</seriesPreference>
<minAgeToStart/>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>24 months - 4 days</absMinAge>
<minAge>24 months</minAge>
<earliestRecAge>24 months</earliestRecAge>
<latestRecAge>24 months</latestRecAge>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV7</vaccineType>
<cvx>100</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal, unspecified formulation</vaccineType>
<cvx>109</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>Pneumococcal Conjugate, unspecified formulation</vaccineType>
<cvx>152</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<allowableVaccine>
<vaccineType>PCV10</vaccineType>
<cvx>177</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge>5 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt>8 weeks</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge>5 years</endAge>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
</inadvertentVaccine>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more doses of PCV13</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>24 months - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Valid</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 2-5 years 3-dose series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>D</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>2 years</minAgeToStart>
<maxAgeToStart>6 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Cerebrospinal fluid leaks</text>
<code>010</code>
</observationCode>
<description>Administer to persons who have cerebrospinal fluid leaks.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Cochlear implants</text>
<code>011</code>
</observationCode>
<description>Administer to persons who have cochlear implants.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance>When cochlear implant placement is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic heart disease</text>
<code>016</code>
</observationCode>
<description>Administer to persons who have chronic heart disease.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic lung disease</text>
<code>017</code>
</observationCode>
<description>Administer to persons who have chronic lung disease.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Asthma</text>
<code>027</code>
</observationCode>
<description>Administer to persons who have asthma.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance>For patients aged 2 through 5 years, asthma is only an indication for vaccination if the patient is treated with high-dose oral corticosteroid therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>2 years</beginAge>
<endAge>6 years</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years</absMinAge>
<minAge>2 years</minAge>
<earliestRecAge>2 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>133</fromMostRecent>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations with greater than 1 dose</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic>AND</conditionLogic>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
<condition>
<conditionID>2</conditionID>
<conditionType>Vaccine Count By Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>OR</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received a complete standard series of vaccinations with greater than 1 dose</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic>AND</conditionLogic>
<condition>
<conditionID>1</conditionID>
<conditionType>Completed Series</conditionType>
<startDate/>
<endDate/>
<beginAge/>
<endAge/>
<interval/>
<doseCount/>
<doseType/>
<doseCountLogic/>
<vaccineTypes/>
<seriesGroups>1</seriesGroups>
</condition>
<condition>
<conditionID>2</conditionID>
<conditionType>Vaccine Count By Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>1</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
<set>
<setID>2</setID>
<setDescription>Dose is not required if the patient has received 3 or more total doses between the ages of 6 weeks and 24 months</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge>24 months</endAge>
<interval/>
<doseCount>2</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>8 weeks - 4 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more doses of PPSV23</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>33</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 1-dose series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>C</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart>65 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Diabetes</text>
<code>014</code>
</observationCode>
<description>Administer to persons who have diabetes.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic liver disease</text>
<code>015</code>
</observationCode>
<description>Administer to persons who have chronic liver disease.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic heart disease</text>
<code>016</code>
</observationCode>
<description>Administer to persons who have chronic heart disease.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Chronic lung disease</text>
<code>017</code>
</observationCode>
<description>Administer to persons who have chronic lung disease.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Asthma</text>
<code>027</code>
</observationCode>
<description>Administer to persons who have asthma.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance>For patients aged 6 through 18 years, asthma is only an indication for vaccination if the patient is treated with high-dose oral corticosteroid therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Smoke cigarettes</text>
<code>042</code>
</observationCode>
<description>Administer to persons who smoke cigarettes.</description>
<beginAge>19 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Alcoholism</text>
<code>043</code>
</observationCode>
<description>Administer to persons who have alcoholism.</description>
<beginAge>6 years</beginAge>
<endAge>65 years</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge>65 years</latestRecAge>
<maxAge>65 years</maxAge>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>133</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years </beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 2-dose PCV-PPSV series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Cerebrospinal fluid leaks</text>
<code>010</code>
</observationCode>
<description>Administer to persons who have cerebrospinal fluid leaks.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Cochlear implants</text>
<code>011</code>
</observationCode>
<description>Administer to persons who have cochlear implants.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance>When cochlear implant placement is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>6 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 2-dose PPSV-PCV series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Cerebrospinal fluid leaks</text>
<code>010</code>
</observationCode>
<description>Administer to persons who have cerebrospinal fluid leaks.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Cochlear implants</text>
<code>011</code>
</observationCode>
<description>Administer to persons who have cochlear implants.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When cochlear implant placement is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal adult risk 2-dose PPSV-PCV series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>B</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Cerebrospinal fluid leaks</text>
<code>010</code>
</observationCode>
<description>Administer to persons who have cerebrospinal fluid leaks.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Cochlear implants</text>
<code>011</code>
</observationCode>
<description>Administer to persons who have cochlear implants.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine/>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 3-dose series PCV-PPSV-PPSV</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>6 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>6 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if patient has already received one dose of PPSV on or after 65 years of age.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count By Age</conditionType>
<startDate/>
<endDate/>
<beginAge>65 years</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>33</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 6-18 years 3-dose PPSV23-PCV13-PPSV23 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge>19 years</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk adult 3-dose PPSV23-PCV13-PPSV23 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose>1</fromTargetDose>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if patient has already received one dose of PPSV on or after 65 years of age.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count By Age</conditionType>
<startDate/>
<endDate/>
<beginAge>65 years</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>33</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk 6-18 years 3-dose PPSV23-PPSV23-PCV13 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>6 years</minAgeToStart>
<maxAgeToStart>19 years</maxAgeToStart>
</selectSeries>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>6 years</beginAge>
<endAge>19 years</endAge>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>6 years</minAge>
<earliestRecAge>6 years</earliestRecAge>
<latestRecAge>19 years</latestRecAge>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>8 weeks</minInt>
<earliestRecInt>8 weeks</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal risk adult 3-dose PPSV23-PPSV23-PCV13 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>2</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>19 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Chronic renal failure</text>
<code>066</code>
</observationCode>
<description>Administer to persons with chronic renal failure.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Severe antibody deficiencies</text>
<code>145</code>
</observationCode>
<description>Administer to persons who have severe B-lymphocyte (humoral) - antibody deficiencies (e.g., X-linked agammaglobulinemia and common variable immunodeficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>B-lymphocyte [humoral] - Less severe antibody deficiencies</text>
<code>146</code>
</observationCode>
<description>Administer to persons who have less severe B-lymphocyte (humoral) - antibody deficiencies (e.g., selective IgA deficiency and IgG subclass deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Complete defects</text>
<code>147</code>
</observationCode>
<description>Administer to persons who have complete cell-mediated or humoral T-lymphocyte defects (e.g., severe combined immunodeficiency [SCID] disease, complete DiGeorge syndrome).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>T-lymphocyte [cell-mediated and humoral] - Partial defects</text>
<code>148</code>
</observationCode>
<description>Administer to persons who have partial cell-mediated or humoral T-lymphocyte defects (e.g., most patients with DiGeorge syndrome, Wiskott-Aldrich syndrome, ataxia- telangiectasia).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Persistent complement, properdin, or factor B deficiency</text>
<code>151</code>
</observationCode>
<description>Administer to persons who have persistent complement component deficiencies, particularly C1, C2, C3, and C4 deficiencies.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Phagocytic function - Leukocyte adhesion defect, and myeloperoxidase deficiency</text>
<code>153</code>
</observationCode>
<description>Administer to persons who have a phagocytic function defect (e.g. leukocyte adhesion defect and myeloperoxidase deficiency).</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - severely immunocompromised</text>
<code>154</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>HIV/AIDS - not severely immunocompromised</text>
<code>155</code>
</observationCode>
<description>Administer to persons who have HIV/AIDS and are not severely immunocompromised (See the CDC general recommendations for a definition of "severely immunocompromised").</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Generalized malignant neoplasm</text>
<code>156</code>
</observationCode>
<description>Administer to persons who have generalized malignant neoplasm.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Transplantation</text>
<code>157</code>
</observationCode>
<description>Administer to persons who have received a transplant.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Immunosuppressive therapy</text>
<code>158</code>
</observationCode>
<description>Administer to persons who are undergoing immunosuppressive therapy. Immunosuppressive medications include those given to prevent solid organ transplant rejection, human immune mediators like interleukins and colony-stimulating factors, immune modulators like levamisol and BCG bladder-tumor therapy, and medicines like tumor necrosis factor alpha inhibitors and anti-B cell antibodies. </description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Radiation therapy</text>
<code>159</code>
</observationCode>
<description>Administer to persons who are undergoing radiation therapy.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When immunocompromising therapy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Anatomical or functional asplenia</text>
<code>160</code>
</observationCode>
<description>Administer to persons with anatomic or functional asplenia, including sickle cell disease.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance>When elective splenectomy is being planned, PCV13 and/or PPSV23 vaccination should be completed at least 2 weeks before surgery or initiation of therapy.</guidance>
</indication>
<indication>
<observationCode>
<text>Nephrotic Syndrome</text>
<code>167</code>
</observationCode>
<description>Administer to persons with nephrotic syndrome.</description>
<beginAge>19 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>2 years - 4 days</absMinAge>
<minAge>19 years</minAge>
<earliestRecAge>19 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if patient has already received one dose of PPSV on or after 65 years of age.</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count By Age</conditionType>
<startDate/>
<endDate/>
<beginAge>65 years</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>33</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 3</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip>
<context>Both</context>
<setLogic>n/a</setLogic>
<set>
<setID>1</setID>
<setDescription>Dose is not required if the patient has received 1 or more total doses to date</setDescription>
<effectiveDate/>
<cessationDate/>
<conditionLogic/>
<condition>
<conditionID>1</conditionID>
<conditionType>Vaccine Count by Age</conditionType>
<startDate/>
<endDate/>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
<interval/>
<doseCount>0</doseCount>
<doseType>Total</doseType>
<doseCountLogic>greater than</doseCountLogic>
<vaccineTypes>133</vaccineTypes>
<seriesGroups/>
</condition>
</set>
</conditionalSkip>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal 65+ 1-dose PPSV23</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>Yes</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard 65+</seriesGroupName>
<seriesGroup>3</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>65 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>65 years</absMinAge>
<minAge>65 years</minAge>
<earliestRecAge>65 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>33</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal 65+ 2-dose PCV13-PPSV23 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard 65+</seriesGroupName>
<seriesGroup>3</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>2</seriesPreference>
<minAgeToStart>65 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>19 years</absMinAge>
<minAge>65 years</minAge>
<earliestRecAge>65 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>33</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge>65 years</absMinAge>
<minAge>65 years</minAge>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>133</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>33</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt>5 years</latestRecInt>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
<series>
<seriesName>Pneumococcal 65+ 2-dose PPSV23-PCV13 series</seriesName>
<targetDisease>Pneumococcal</targetDisease>
<vaccineGroup>Pneumococcal</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Standard</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Standard 65+</seriesGroupName>
<seriesGroup>3</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>3</seriesPreference>
<minAgeToStart>65 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication/>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>65 years</absMinAge>
<minAge>65 years</minAge>
<earliestRecAge>65 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>N</fromPrevious>
<fromTargetDose/>
<fromMostRecent>33</fromMostRecent>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>5 years</minInt>
<earliestRecInt>5 years</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PPSV23</vaccineType>
<cvx>33</cvx>
<beginAge>2 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
<seriesDose>
<doseNumber>Dose 2</doseNumber>
<age>
<absMinAge/>
<minAge/>
<earliestRecAge/>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval>
<fromPrevious>Y</fromPrevious>
<fromTargetDose/>
<fromMostRecent/>
<fromRelevantObs/>
<absMinInt>0 days</absMinInt>
<minInt>1 year</minInt>
<earliestRecInt>1 year</earliestRecInt>
<latestRecInt/>
<intervalPriority/>
<effectiveDate/>
<cessationDate/>
</interval>
<allowableInterval/>
<preferableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>0.5</volume>
<forecastVaccineType>Y</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>PCV13</vaccineType>
<cvx>133</cvx>
<beginAge>6 weeks - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
